Source link : https://newshealth.biz/health-news/darolutamide-plus-adt-in-metastatic-hormone-sensitive-prostate-cancer/
(MedPage Today) — New data presented at the American Urological Association (AUA) annual meeting further supported the use of darolutamide (Nubeqa) in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive… Source link : https://www.medpagetoday.com/meetingcoverage/auavideopearls/115825 Author : Publish date : 2025-05-30 17:50:00 Copyright for syndicated content belongs to the linked Source.
The post Darolutamide Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-30 17:50:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8